Member Info for TorquayFan

C7 good to see your thoughts. The SP nicely poised ? As always M8 ! I just want to check that you are not angry with RG anymore ? Your second sentence - news can come at any time of course. What Richard thinks of the BB I dread to think. Your final sentence - my thought - I'm sure CH IS very much in charge now and makes his own path - if not he's the wrong Man. Richard's help we take for granted. I hope he manages to enjoy his retirement. IMO we will all win as a result of the science ? And the great teamwork - past and present !

Really, I'm not trying to pour cold water - but by the time 55 people have filed in and sat down - and got out again - maybe that could have happened - quickly. Or not. Newbies would struggle with even that small amount of admittedly wonderful data in a 10 minute time span. Myself I rather hope it WAS 6 Folks already IN the network fully, having further updates. And being made aware of the commercial aspects - just to show WE Scancell, know too. We Posters are agonising about it all but we don't know - until that RNS hits. We might not see it coming. ATB

55 is better ! But only 15 minutes ? It'd be good to know. Maybe there'll be at least a tweet later. (The link showed maybe 100 small booths). ATB Konar thanks for that insight. Most interesting ! ATB

14 pence. More please. Looking for my humble hat . .

Hi Guys. You may be right in which case I will humbly . . . . . But in this link it says : Theatre 1, 1.30 -1.45. Attending 6. https://mybio.org/event/member?item_id=7980030 I also looked at the link in Bermuda's Sun 19.58 replying to DA's query Sun 18.47. BS : ''It's the standard format for these partnering conferences. I think that out of the 1000+ companies attending only around 200 will be making presentations. It's a massive conference though with over 16000 attendees.'' Roses - 00.15 I posted, ''I'm guessing that this meet is arranged to update previously networked contacts on some aspect or other.'' If that surmise is correct, it's a more advanced discussion - so that's very positive ! And Wed 00.36 - re. Grand Challenge : ''All the applications are very worthy of course, but it strikes me that 9 applications are trying to get to answers whereas Scancell have already got theirs and are working towards implementation of what they know already. In the other headers we see 'Uncovering', 'Unravelling', want to find', 'want to analyse', 'want to create' all of which is good but there is a contrast when you get to Scancell, where 'ERADICATING' is the word ! I guess we all think that Scancell have a very strong application - roll on November then. That's positive too. ATB

Hi. The Placing/OO was 'left field' ? Ouch ! Hopefully something else 'left field' coming too . . . . News might come from any direction - another Scancell surprise ? ATB

Isn't this CH talk just 15 mins in one of a hundred booths or more. Six people ? Of course if they each want to spend a � billion that would be lovely ! C7 I agree with you about the Calculus show, it was excellent. But it was 55 minutes long and CH wouldn't have enough time evn to 'overview'. I'm guessing that this meet is arranged to update previously networked contacts on some aspect or other. But who knows ? I wonder if we'll be told about the content of the meet ? GLA

I agree with your post - enough science and framework for a bit more banging of the drum. CH promised news1st half did he not and that time is getting close. GLA

Yes WF but not a mention of cancer vaccines . . . . I noted this bit - now just what is he driving at ? ''The question .... has been to find a way to isolate these rare, highly competent immune cells, then grow them in sufficient numbers to create the sort of immunological army that could tackle the billions of rogue cells that make up a tumour.'' Sounds like the good ole' T-Cells to me ? Come on Scancell !

Thanks GF - that prompted me to have a further look at the 10 shortlisted 'Grand Challengers' again. Re. Scancell, Prof. Bernard's introductory comment is : ''The academic-biotech-clinical partnerships in this application are really unique, the different perspectives that each discipline brings makes this team�s proposal comprehensive, innovative and therefore very powerful.'' Right. All the applications are very worthy of course, but it strikes me that 9 applications are trying to get to answers whereas Scancell have already got theirs and are working towards implementation of what they know already. In the headers we see 'Uncovering', 'Unravelling', want to find', 'want to analyse', 'want to create' all of which is good but there is a contrast when you get to Scancell, where 'ERADICATING' is the word ! I guess we all think that Scancell have a very strong application - roll on November then . . . I'm not sure I've explained that too well but you see where I'm coming from ? http://www.cancerresearchuk.org/funding-for-researchers/how-we-deliver-research/grand-challenge-award/shortlistedteamdurrant

Courtesy of 10acious on ADVFN - an update from Ichor :- ''Ichor announced today the first in human dosing of JNJ-64300535, an investigational DNA vaccine candidate being developed by Janssen Pharmaceutical Companies for patients with chronic hepatitis B virus (HBV) infection, with its next generation investigational TriGrid� Delivery System. This is both the first human administration using Ichor�s next generation TriGrid Delivery System and the first in human dose of JNJ-64300535 (Clinicaltrials.gov identifier: NCT03463369). Ichor�s patented and newly designed TriGrid Delivery System builds on the successes of the first generation device, which has been utilized in >25 clinical studies, including randomized comparative studies, demonstrating that DNA vaccination with the TriGrid device significantly enhances immune responses to delivered vaccines compared to conventional injection. The next generation TriGrid incorporates the same fundamental integrated and automated design features for clinical use as its predecessor, while complying with the U.S. and international device standards necessary to support worldwide commercial deployment of the device. Ichor is pleased to be supporting the development of immunotherapies for patients suffering from chronic HBV infection. With the start of this first clinical trial utilizing Ichor�s next generation TriGrid System, Ichor and its many partners enter an exciting time with the initiation of multiple additional clinical trials in oncology and chronic viral infection anticipated by the end of this year''. Good to see Ichor in use . . .

Thanks for the link C7 and it's still raining - so I picked some bits out :- ''The results of the KEYNOTE-042 trial, reported at ASCO over the weekend, showed that giving Keytruda (pembrolizumab) to previously-untreated NSCLC patients improved survival by four to eight months compared to standard platinum-based chemo, and as might be expected significantly reduced the side effect burden. . .'' ''As it stands, Merck�s lead in the big NSCLC market only looks likely to be maintained in the wake of the ASCO presentations, with the chemotherapy combination likely to remain first-choice for many patients and monotherapy an option for those who can�t or don�t wish to go down the chemotherapy route.'' Undeniably any advance is good news but this leaves plenty of room for improvement - roll on our SCIB 2 trial !

Forgot to mention this - JC and CH will be able to go bopping tonight in the Convention Hall - to the music of the one and only, Diana Ross ! Bet that cost a bob or two . .

As observed this is a massive but massive gathering. I noticed that BioNTech have 2 present, COO Sean Maret and their 'DO', Genetech about 15 and Roche, 2 football teams at least. I looked but might have missed Ichor ? Let's hope whoever the 6 are, will have plenty to talk about with JC and CH ? Impossible to know if anything, or what, might come out of it. Re. the Ms. Perkins story - well done her. Imagine the potential news coverage when Scancell get the CRUK prize and some good SCIB2, SCIB1 Combo and Moditope results. I wonder if BioNTech have any thoughts as the TCR cooperation progresses ? GLA

ASCO ? Maybe CH had a quick flight to 'Spotlight' town ? Or not. We can't expect to be informed of every meet or phone call or flight.. BoD have it sussed IMO. The framework is going into place and the science won't stop ! Trebor - to worry about the travel X may be off line. DA - pertinent questions indeed. C7 - I'm just saying the abuse you get must hurt, whatever you say - so don't go there. No point. But UtY. (Up to you). Where is Inan ? Goodnight all.

I never post on VAL and on ADVFN once a week if that - (btw I have the filters off now but don't read 'some' of the posters very often !). I see you get a lot of abuse there and it must be depressing. Glad you got out this weekend - it's pelting down here ! Never mind - a big fat RNS will cheer us up soon. ATB

Hi C7. I see you have been scrapping on VAL and the other place too. Doesn't it get you down ? It would me. Arguing here is bad enough LOL. TCOY.

Calm down C7. I asked my questions carefully. As for ''frequently, words about me which you have eagerly posted will never be forgotten''. Good - I stand by my words before but I have moved on now. I don't focus on your posts and really try not to pick up on every issue. But I do ask questions sometimes, be it you or whoever. And why not ? Your 19.44 :- ''I am very sympathetic to the restrictions that can delay news. I just hope that Scancell are as aware that traders and Pis should know certain information. I don't think in the last three years we have found that balance.'' Are you accusing Scancell of restricting or withholding news ? Scancell can't balance communications with Traders and PI ? What ? Scancell give separate news to 'Traders' ? How would they achieve that ? BoD have failed to get 'balance' in 3 years ? I'm sorry M8 but that reads as twaddle to me. Never mind. Here's to a good blue week eh ? And maybe some News when the BoD have something of significance to impart. (BTW My comments on Share Society were not about PR but about presenting commercial insights and implications to potential investors. NOT a 'dumb down' but a wise up !). ATB

Oh wise one ! I defer to your great knowledge of England cricket and hope that Scancell too, have a rampant win on the way. ATB

Good morning. You posted : ''I am very sympathetic to the restrictions that can delay news. I just hope that Scancell are as aware that traders and Pis should know certain information. I don't think in the last three years we have found that balance.'' I didn't really understand your point(s). But I'll try this response - meetings / discussions are not news until a conclusion is reached - at that point, an RNS informs traders/PI's alike ? What did you mean about 'not finding that balance'? Scancell 'as aware' as whom? What is it that we should know? Restrictions ? I'm not being difficult M8, but can you clarify all that please? ATB